Precision ophthalmic lens with Eyesafe spectral filtration technology
Introducing

Digital Wellness Optics

The science-backed lens technology platform engineered for how modern devices emit light — and how that light affects human biology.

A Multi-Billion-Dollar Market Built on an Inadequate Scientific Foundation

The blue light eyewear market is projected to reach $5.8 billion by 2034. Consumer demand is accelerating at 8–10% annually. 94% of consumers cite scientific validation as the most important factor in their purchase decision.

Yet the category faces a credibility crisis. The 2023 Cochrane systematic review of 17 randomized controlled trials found that existing blue light filtering lenses showed no benefit for eye strain, sleep quality, or macular health.

The reason is not that the science of spectral photobiology is wrong. The reason is that the products were never designed to apply it correctly.

Five structural gaps define the current category — and one platform is engineered to close all five simultaneously.

01
No Standard No SPF-equivalent metric exists. Consumers and ECPs cannot compare products.
02
No Biological Targeting Products filter broadly across 380–500 nm instead of targeting specific action spectra.
03
No Device Alignment No product distinguishes between LED/LCD and OLED emission profiles.
04
No Clinical Evidence The Cochrane review confirmed: no existing product has published outcome data.
05
No Consumer Metric No "higher number = more protection" rating for purchase decisions.
One platform is engineered to close all five.

It Starts with the Light Your Devices Emit

The average person spends 11+ hours per day in front of digital screens — at distances of 4 to 18 inches from the face. Over a lifetime, that equates to more than 20 years of cumulative screen exposure.

LED and LCD displays use a blue LED backlight paired with phosphor conversion, producing a sharp emission spike at approximately 460 nm followed by a broad phosphor hump across 500–700 nm. OLED displays use three discrete organic emitters — blue (~460 nm), green (~530 nm), and red (~625 nm) — each producing a narrow spectral peak. Both technologies concentrate peak energy at the wavelengths associated with retinal phototoxicity (435–440 nm) and circadian disruption (480–500 nm).

LED / LCD Display
Monitors · Laptops · Office Displays
LED/LCD spectral emission profile showing sharp blue peak at 460nm and broad phosphor hump from 500-700nm
Peak emission at ~460 nm — the retinal phototoxicity zone A blue LED backlight produces a sharp high-energy spike, while phosphor conversion generates a broad secondary emission from 500–700 nm. The spike concentrates maximum energy precisely at the wavelengths linked to photochemical retinal cell stress.
OLED Display
Smartphones · Tablets · Premium TVs
OLED spectral emission profile showing three distinct peaks at 460nm, 530nm, and 625nm
Three narrow peaks — each from a discrete organic emitter Blue (~460 nm), green (~530 nm), and red (~625 nm) emitters produce isolated spectral peaks with near-zero emission between them. The blue emitter peak falls directly in both the retinal hazard zone and the circadian disruption band (480–500 nm).

Two different display technologies. Two different spectral profiles. Both concentrate energy at the wavelengths where human biology is most vulnerable. Any effective solution must address both.

Two Pathways. Two Targets. One Platform.

Every Eyesafe product is engineered around two specific biological pathways — each backed by decades of peer-reviewed photobiology research and internationally recognized action spectra.

RPF
Retinal Phototoxicity Pathway
RPF Zone · 415–455 nm
RPF ZONE 380 415–455 500 600 750 VISIBLE SPECTRUM (nm)

The human retina is most vulnerable to photochemical damage in the 415–455 nm wavelength band, peaking at the ICNIRP Blue Light Hazard Function B(λ) around 435–440 nm. Both LED and OLED displays concentrate their blue emission energy precisely in this zone. Eyesafe RPF targets this band with precision — filtering the wavelengths that drive cumulative retinal damage while preserving visual clarity and color fidelity.

CPF
Circadian Disruption Pathway
CPF Zone · 455–500 nm
CPF ZONE 380 455–500 600 750 VISIBLE SPECTRUM (nm)

Melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) regulate the body's circadian clock, melatonin production, and sleep-wake cycles. Their peak sensitivity falls in the 455–500 nm band, centered around 480 nm. OLED displays — now dominant in smartphones, tablets, and premium monitors — emit strongly in this region. Eyesafe CPF targets the melanopic sensitivity peak, reducing circadian disruption without amber tinting.

Standardized. Quantified. Verified.

Digital Wellness Optics introduces the first measurement framework for digital light protection — grounded in internationally recognized photobiological science, verified by spectrophotometric testing, and structured as tiered scales where higher numbers mean more protection.

RPF RATING 20 40 60 80
Radiance Protection Factor
Measures filtration of high-energy blue light at the retinal hazard peak — the wavelengths linked to photochemical eye strain and retinal cell stress.
Target: 435–440 nm · LED / LCD displays
CPF RATING 20 40 60 80
Circadian Protection Factor
Measures filtration of melanopic-stimulus blue light — the wavelengths that suppress melatonin production and disrupt sleep-wake cycles.
Target: 480–500 nm · OLED displays

3–10× the Protection at the Wavelengths That Matter

RPF Performance — Peak Filtration at 435–440 nm (LED Display)
Eyesafe RPF80
80%
Eyesafe RPF60
60%
Eyesafe RPF50
50%
Common Product B
34%
Common Product C
25%
Common Product F
15%
Common Product D
11%
Common Product E
9%
CPF Performance — Peak Filtration at 480–500 nm (OLED Display)
Eyesafe CPF70
72%
Eyesafe CPF50
51%
Eyesafe CPF30
31%
Common Product B
15%
Common Product F
13%
Common Product C
12%
Common Product D
9%
Common Product E
9%

Eyesafe CPF70 delivers 72% peak filtration at 480–500 nm — the circadian impact zone. The best-performing common industry product in benchmarking measured 15%. Most measured below 10%.

The performance gap is not incremental. It is categorical.

Spectrophotometric benchmarking of commercially available lenses. Filtration measured at peak biological impact zones per ICNIRP B(λ) and CIE S 026 smel(λ). Common industry products anonymized. Data on file, Eyesafe Inc. 2026.

Lenses Designed for Modern Digital Life

Eyesafe RPF lens with LCD monitor
Eyesafe RPF
LCD-Aligned

Precision filtration at the retinal hazard peak. Reduces photochemical eye strain while preserving color accuracy and visual clarity for all-day screen use.

RPF Rating: 30–80
Eyesafe CPF lens with OLED smartphone
Eyesafe CPF
OLED-Aligned

Precision filtration at the melanopic sensitivity peak. Supports healthy circadian rhythms and better sleep by reducing the light that suppresses melatonin.

CPF Rating: 30–80

Digital Light Protection
With Independent Clinical Validation

Eyesafe is building the clinical evidence base for digital light management — validating real outcomes across eye comfort, sleep quality, and productivity through independent research partnerships.

Research Study Outcomes · 2024
CPF70 Screen Protection — Sleep & Comfort

Objectively measured SleepScore data showed measurable improvement in sleep quality and deep sleep duration.

Self-reported improvements:
95% reported eyes felt less strained or tired
87% woke up feeling more refreshed
76% felt the protector helped improve their sleep

SleepScore Labs, 2024. n=45 adults, 1,400 sleep nights.

Research Study Outcomes · 2025
Dell XPS with Eyesafe Display — Sleep & Comfort

Self-reported data showed strong perceived benefits across sleep, eye comfort, and productivity.

Self-reported improvements:
67% felt XPS helped improve their sleep
53% woke up feeling more refreshed
38% felt more productive more days per week

SleepScore Labs, 2025. n=25 adults, 700 sleep nights.

Active Research Programs

Expanded clinical studies on Eyesafe Optical lenses are now underway with two world-class research partners.

Mount Sinai Light & Health Research Center

Clinical evaluation of Eyesafe RPF and CPF ophthalmic lenses across graded attenuation levels. Measuring eye comfort, digital eye strain, visual clarity, reaction time, sleep quality, and next-day productivity.

In progress · Results expected 2026
SleepScore Labs — Optical Lens Study

Expanded validation study applying Eyesafe's CPF technology to ophthalmic lens form factors. Objective sleep measurement combined with comfort and performance metrics across extended wear periods.

In progress · Results expected 2026

Proven at Scale. Trusted by the World's Leading Brands.

Eyesafe technology and certification standards are adopted by the world's premier consumer electronics manufacturers. Over half a billion devices with Eyesafe technology are in use worldwide.

Dell Samsung HP Lenovo LG Display ZAGG UL Solutions TÜV Rheinland United Healthcare GIGABYTE Belkin imos BenQ TCL Acer Kensington Sysco LifeSpeak Dell Samsung HP Lenovo LG Display ZAGG UL Solutions TÜV Rheinland United Healthcare GIGABYTE Belkin imos BenQ TCL Acer Kensington Sysco LifeSpeak
500M+
Eyesafe units in consumer electronics
28.5%
Proven retail premium for Eyesafe-branded products
100+
Patents and trade secret formulations in digital light management
1.6B+
Projected units by 2030

The Platform Behind
the Next Generation of Lenses.

Eyesafe is a technology and certification platform designed to serve the optical industry. We provide the science, the IP, the clinical evidence, and the consumer story. You provide the manufacturing excellence, the distribution, and the patient relationships.

Technology Licensing

RPF and CPF formulations, spectral design specifications, and dye chemistry for your lens manufacturing process. Compatible with CR39, 1.6 index, and polycarbonate substrates through in-mass, imbibition, coating-integrated, and hybrid implementation paths.

Product Certification

UL Solutions-verified RPF, CPF, and DPF ratings on finished lenses. Independent, third-party verified performance ratings that give ECPs and consumers confidence in measurable protection levels.

Co-Branded Marketing

Eyesafe Digital Wellness Certified mark for lens packaging, in-store displays, and ECP marketing materials. Access to consumer preference data, premium pricing insights, and category positioning frameworks.

Clinical & Claims Support

Access to clinical evidence from Mount Sinai and SleepScore research programs. Evidence-based claims frameworks for regulatory and marketing teams. Training materials for ECPs and sales forces.

Lead the Next Era of Optics.

Partner with Eyesafe to bring the first science-backed, clinically validated digital light protection platform to your lens portfolio.

Scroll to Top